at Ayr 2m 5f hcp (5) sft in Jan. Toucan Sam 18-1 (11-1) Held up in rear, driven before 6th, plenty to do before 2 out, stayed on run-in, no danger, 5th of 12, 11 3/4l behind Tread Softly Now (10-5 ...

Nasal spray is being recalled over microbial failure. The U.S. Food and Drug Administration shared information about the recall affecting NeilMed Pharmaceuticals’ NasoGel Spray, last week.

If you suffer from allergies or sinus congestion, you might want to think twice before using this nasal spray. The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal ...

When Ayr United make the trip to West Lothian tomorrow, it will arguably be the most high profile home game in the Albyn Park club’s history. Having had various periods of both positives and ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

NAB WOOD looks rock solid to win the racingtv.com/freetrial Handicap Hurdle (2.52) over two miles, four and a half furlongs at Ayr. Nicky Richards’ eight-year-old ...

The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.

We'll wrap this up here, with Celtic and Kilmarnock opening the late start in lively fashion. Here are the teams through to the fifth round of the Scottish Cup. Tomorrow, we have Falkirk v Raith ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...